首页> 外文期刊>Journal of International Medical Research >Conversion to hemi-shoulder arthroplasty or reverse total shoulder arthroplasty after failed plate osteosynthesis of proximal humerus fractures: a retrospective study
【24h】

Conversion to hemi-shoulder arthroplasty or reverse total shoulder arthroplasty after failed plate osteosynthesis of proximal humerus fractures: a retrospective study

机译:转换为半肩关节塑料或逆转总肩部关节置换术后近端肱骨骨折的骨质合成后:回顾性研究

获取原文
       

摘要

Objective To assess the clinical outcomes of hemi-shoulder arthroplasty (HSA) versus reverse total shoulder arthroplasty (RTSA) following failed plate osteosynthesis of proximal humerus fractures in elderly patients. Methods This retrospective study identified all patients that had a documented failed plate osteosynthesis of proximal humeral fractures treated with revision HSA or RTSA. Follow-up occurred at 1, 3, 6 and 12 months after surgery and every year thereafter. The primary outcomes were the American Shoulder and Elbow Surgeons (ASES) scores, Simple Shoulder Test (SST) scores, visual analogue scale (VAS) pain scores and the University of California, Los Angeles Shoulder Rating Scale (UCLA SRS) scores. The secondary outcome was the rate of major complications. Results A total of 126 patients (126 shoulders) were enrolled in the study. At the final follow-up, the RTSA group had significantly greater improvements in ASES, SST and UCLA SRS scores than the HSA group. The RTSA group had significantly larger decreases in the VAS pain score compared with the HSA group. The rate of major complications was significantly higher in the HSA group than in the RTSA group (44.4% versus 27.5%, respectively). Conclusion RTSA provided superior functional outcomes compared with HSA, with a lower rate of major complications after a follow-up period of at least 5 years.
机译:目的评估半肩关节成形术(HSA)的临床结果与老年患者近端肱骨骨折的板骨混合失败后的逆转总肩部表成术(RTSA)。方法本回顾性研究鉴定了所有具有修订HSA或RTSA治疗的近端肱骨骨折的记录失败的板骨合成的患者。随访时间发生在手术后的1,3,6和12个月,此后每年都发生。主要成果是美国肩部和肘部外科医生(ASES)分数,简单的肩部测试(SST)分数,视觉模拟量表(VAS)疼痛分数和加州大学,洛杉矶肩标评定量表(UCLA SRS)得分。二次结果是主要并发症的速度。结果共有126名患者(126名患者)参加该研究。在最后的后续行动中,RTSA集团在比HSA集团的分数上大大提高了改进.PS SST和UCLA SRS分数。与HSA组相比,RTSA组在VAS疼痛评分中显着较大。 HSA组主要并发症的主要并发症率明显高于RTSA组(分别为44.4%,分别为27.5%)。结论RTSA与HSA相比提供了卓越的功能结果,后续时间至少为5年后的主要并发症率较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号